Clinical Trial Update: Safety and Viability of an E. Coli Nissle Colibactin Knockout in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 safety and feasibility evaluation of a genetically modified Escherichia coli Nissle strain lacking colibactin, studied in healthy volunteers; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Escherichia coli Nissle Colibactin Knockout (Escherichia coli Nissle colibactin knockout strain)

Snippet

Sponsor: Max Nieuwdorp | Conditions: Diabetes | Phase 1 | Status: COMPLETED